We announce that new shares have been issued through a third-party allotment to investors including Tokyu Agency Inc. for business expansion, support of R&D, and overseas expanion of the nematode cancer test “N-NOSE.”
HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”), has signed on . . .
2024.10.04HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)), has recently . . .
2024.08.02In May 2024, the Indonesian healthcare company PT Jaya Prima Alkatra visited our company, and Press Release regarding this visit has been issued . . .
2024.08.01